A detailed history of Charles Schwab Investment Management Inc transactions in Chroma Dex Corp. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 140,169 shares of CDXC stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
140,169
Previous 140,169 -0.0%
Holding current value
$1.07 Million
Previous $382,000 33.77%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$2.44 - $4.32 $281,824 - $498,968
115,502 Added 468.25%
140,169 $382,000
Q2 2022

Aug 15, 2022

SELL
$1.59 - $2.7 $163,720 - $278,016
-102,969 Reduced 80.67%
24,667 $42,000
Q4 2021

Feb 11, 2022

BUY
$3.74 - $6.7 $18,041 - $32,320
4,824 Added 3.93%
127,636 $478,000
Q3 2021

Nov 16, 2021

BUY
$6.05 - $10.41 $32,440 - $55,818
5,362 Added 4.57%
122,812 $771,000
Q2 2021

Aug 16, 2021

BUY
$6.66 - $10.92 $73,166 - $119,967
10,986 Added 10.32%
117,450 $1.16 Million
Q1 2021

May 17, 2021

BUY
$4.59 - $18.74 $24,744 - $101,027
5,391 Added 5.33%
106,464 $995,000
Q4 2020

Feb 16, 2021

BUY
$3.93 - $5.5 $19,276 - $26,977
4,905 Added 5.1%
101,073 $486,000
Q3 2020

Nov 13, 2020

SELL
$4.01 - $5.56 $17,796 - $24,675
-4,438 Reduced 4.41%
96,168 $386,000
Q2 2020

Aug 14, 2020

BUY
$3.0 - $5.52 $8,019 - $14,754
2,673 Added 2.73%
100,606 $462,000
Q1 2020

May 15, 2020

SELL
$2.54 - $4.75 $11,450 - $21,413
-4,508 Reduced 4.4%
97,933 $320,000
Q4 2019

Feb 07, 2020

BUY
$2.83 - $4.61 $14,650 - $23,865
5,177 Added 5.32%
102,441 $442,000
Q3 2019

Nov 08, 2019

BUY
$3.83 - $4.72 $22,574 - $27,819
5,894 Added 6.45%
97,264 $383,000
Q2 2019

Aug 09, 2019

BUY
$3.71 - $4.83 $25,524 - $33,230
6,880 Added 8.14%
91,370 $425,000
Q1 2019

May 14, 2019

BUY
$3.2 - $4.19 $40,608 - $53,171
12,690 Added 17.67%
84,490 $355,000
Q2 2018

Aug 08, 2018

BUY
$3.22 - $4.43 $231,196 - $318,074
71,800 New
71,800 $267,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $522M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.